Literature DB >> 33621975

Respiratory Muscle Weakness as a Risk Factor for Pneumonia in Older People.

Tatsuma Okazaki1,2, Yoshimi Suzukamo3, Midori Miyatake3, Riyo Komatsu4, Masahiro Yaekashiwa5, Mayumi Nihei5, Shinichi Izumi3,6,7, Takae Ebihara8.   

Abstract

INTRODUCTION: The respiratory muscle strength regulates the effectiveness of coughing, which clears the airways and protects people from pneumonia. Sarcopenia is an aging-related loss of muscle mass and function, the worsening of which is associated with malnutrition. The loss of respiratory and swallowing muscle strength occurs with aging, but its effect on pneumonia is unclear. This study aimed to determine the risks of respiratory muscle weakness on the onset and relapse of pneumonia in older people in conjunction with other muscle-related factors such as malnutrition.
METHODS: We conducted a longitudinal study with 47 pneumonia inpatients and 35 non-pneumonia controls aged 70 years and older. We evaluated the strength of respiratory and swallowing muscles, muscle mass, and malnutrition (assessed by serum albumin levels and somatic fat) during admission and confirmed pneumonia relapse within 6 months. The maximal inspiratory and expiratory pressures determined the respiratory muscle strength. Swallowing muscle strength was evaluated by tongue pressure. Bioelectrical impedance analysis was used to evaluate the muscle and fat mass.
RESULTS: The respiratory muscle strength, body trunk muscle mass, serum albumin level, somatic fat mass, and tongue pressure were significantly lower in pneumonia patients than in controls. Risk factors for the onset of pneumonia were low inspiratory respiratory muscle strength (odds ratio [OR], 6.85; 95% confidence interval [CI], 1.56-30.11), low body trunk muscle mass divided by height2 (OR, 6.86; 95% CI, 1.49-31.65), and low serum albumin level (OR, 5.46; 95% CI, 1.51-19.79). For the relapse of pneumonia, low somatic fat mass divided by height2 was a risk factor (OR, 20.10; 95% CI, 2.10-192.42). DISCUSSION/
CONCLUSIONS: Respiratory muscle weakness, lower body trunk muscle mass, and malnutrition were risk factors for the onset of pneumonia in older people. For the relapse of pneumonia, malnutrition was a risk factor.
© 2021 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Aged people; Muscle strength; Pneumonia; Respiratory muscles; Sarcopenia

Year:  2021        PMID: 33621975     DOI: 10.1159/000514007

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  5 in total

Review 1.  How can Biology of Aging Explain the Severity of COVID-19 in Older Adults.

Authors:  Antonella Gallo; Erika Pero; Simona Pellegrino; Noemi Macerola; Celeste Ambra Murace; Francesca Ibba; Maria Chiara Agnitelli; Francesco Landi; Massimo Montalto
Journal:  Clin Geriatr Med       Date:  2022-04-22       Impact factor: 3.529

2.  Correlation of CT-derived pectoralis muscle status and COVID-19 induced lung injury in elderly patients.

Authors:  Pei Ying-Hao; Zhang Hai-Dong; Fang Yuan; Liu Yong-Kang; Liang Sen; Xu Wei-Long; Yang Yu-Shan; Zhu Jun-Feng; Zhou Hai-Qi; Jiang Hua
Journal:  BMC Med Imaging       Date:  2022-08-12       Impact factor: 2.795

3.  Association between the mid-upper arm circumference (MUAC) and calf circumference (CC) screening indicators of sarcopenia with the risk of pneumonia in stable patients diagnosed with schizophrenia.

Authors:  Silan Ren; Sha Huang; Ming Chen; Tian Zhu; Qiuxia Li; Xiaoyan Chen
Journal:  Front Psychiatry       Date:  2022-08-26       Impact factor: 5.435

4.  Effect of decreased tongue pressure on dysphagia and survival rate in elderly people requiring long-term care.

Authors:  Yuki Sakamoto; Gohei Oyama; Masahiro Umeda; Madoka Funahara; Sakiko Soutome; Wataru Nakamura; Yuka Kojima; Hiroshi Iwai
Journal:  J Dent Sci       Date:  2021-10-07       Impact factor: 3.719

5.  A Paradigm Shift in the Diagnosis of Aspiration Pneumonia in Older Adults.

Authors:  Yuki Yoshimatsu; David G Smithard
Journal:  J Clin Med       Date:  2022-09-03       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.